Alyeska Investment Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-253,468
Closed -$494K 706
2025
Q4
$494K Hold
253,468
﹤0.01% 558
2025
Q3
$214K Hold
253,468
﹤0.01% 575
2025
Q2
$184K Hold
253,468
﹤0.01% 538
2025
Q1
$218K Hold
253,468
﹤0.01% 486
2024
Q4
$426K Sell
253,468
-187,550
-43% -$449K ﹤0.01% 521
2024
Q3
$1.26M Hold
441,018
0.01% 448
2024
Q2
$1.03M Hold
441,018
0.01% 462
2024
Q1
$1.3M Hold
441,018
0.01% 402
2023
Q4
$1.32M Sell
441,018
-4,968
-1% -$14.2K 0.01% 395
2023
Q3
$1.41M Hold
445,986
0.01% 405
2023
Q2
$1.73M Sell
445,986
-30,443
-6% -$87.7K 0.01% 418
2023
Q1
$1.32M Hold
476,429
0.01% 379
2022
Q4
$858K Hold
476,429
0.01% 356
2022
Q3
$1.01M Sell
476,429
-19,557
-4% -$49.2K 0.01% 342
2022
Q2
$1.33M Hold
495,986
0.02% 445
2022
Q1
$2.15M Hold
495,986
0.02% 409
2021
Q4
$2.57M Hold
495,986
0.03% 399
2021
Q3
$3.04M Sell
495,986
-919,653
-65% -$7.33M 0.04% 417
2021
Q2
$13.5M Buy
1,415,639
+668,648
+90% +$7.24M 0.16% 177
2021
Q1
$10.3M Sell
746,991
-53,009
-7% -$734K 0.14% 196
2020
Q4
$8.68M Sell
800,000
-6,400
-0.8% -$67.4K 0.13% 212
2020
Q3
$8.72M Buy
+806,400
New +$8.6M 0.14% 194

Other funds holding NAUT